Hydrocodone Addiction

Understanding Hydrocodone Addiction and Physical Dependence

Feeling unwell when you miss hydrocodone can be frightening. Physical dependence can develop during prescribed treatment. It does not by itself mean addiction. A medication review can address withdrawal, pain, side effects, or use that feels hard to control without assuming which problem you have.^[1][2]

Hydrocodone is an opioid in some prescription pain and cough medicines. Check the whole label, including ingredients such as acetaminophen. Talk with the prescriber before stopping regular use suddenly. If opioid use disorder is diagnosed, medication treatment can help.^[1][3][4]

When Hydrocodone Exposure Needs Emergency Help

Call 911 if someone cannot be awakened or has slow or stopped breathing after opioid use. Give naloxone if available. Follow the dispatcher’s instructions to help the person breathe.^[5]

If they are breathing normally but unconscious and no head, neck or back injury is suspected, place them on their side. If an injury is suspected, follow the dispatcher’s instructions and leave them in the position found unless moving them is necessary for safety, cardiopulmonary resuscitation (CPR) or bleeding control. Stay until help arrives. Naloxone temporarily reverses opioid overdose and does not replace emergency care.^[6][5][7]

Fast Facts About Hydrocodone

Keep these distinctions in mind when discussing hydrocodone use.

• Hydrocodone products differ: some treat severe pain, some treat cough, and some contain another active medicine, so the complete label matters.^[1]
• Physical dependence means the body has adapted to an opioid and may develop withdrawal after a sudden change. It is not, by itself, the same as opioid use disorder.^[8]
• People with opioid use disorder who are treated with methadone or buprenorphine are less likely to die or to have an overdose than those who do not receive treatment.^[4]
• For a suspected opioid overdose, call 911 and give naloxone if available. Follow dispatcher instructions for breathing support and stay until help arrives.^[6][5]

How Do Hydrocodone Products Differ?

Hydrocodone belongs to the opioid family, and its products differ in important ways. Product-specific features include separate pain and cough uses, availability in combination medicines, and both shorter-acting and extended-release formulations, which release medicine over a longer period.^[1]

An opioid is a drug that acts on systems involved in pain, breathing, alertness, and other functions. Hydrocodone changes how the brain and nervous system respond to pain. When used for cough, it decreases activity in the part of the brain involved in triggering coughing.^[1]

Hydrocodone should not be treated as interchangeable with oxycodone or another opioid. They are different medicines, and the combined long-term study of extended-release oxycodone and hydrocodone does not establish equal effectiveness or equal risk, or show which doses would produce comparable effects.^[9]

Pain and Cough Products Serve Different Purposes

Some hydrocodone combination products are prescribed for severe pain. Other combinations are used to relieve cough. A cough product should not be understood as simply a liquid version of a pain prescription, even if both contain hydrocodone. The intended use, additional ingredients, formulation, and instructions can differ.^[1]

Combination products contain hydrocodone plus at least one other active ingredient. The National Library of Medicine advises patients to read information about every ingredient and ask a clinician or pharmacist about anything unclear.^[1]

Immediate-Release and Extended-Release Products Differ

Hydrocodone combination products can come as tablets, syrup, solution, or an extended-release suspension. “Extended-release” means the formulation releases medicine over a longer period rather than all at once. Different products therefore have different schedules, measuring requirements, and handling instructions.^[1]

A separate single-ingredient, once-daily extended-release hydrocodone product was reviewed for pain severe enough to require daily, around-the-clock, long-term opioid treatment when alternatives were inadequate. It was designed to maintain hydrocodone concentrations and pain relief over 24 hours.^[10] That indication should not be generalized to every hydrocodone product.^[10]

That extended-release product had properties intended to make physical manipulation harder. In a clinical study, intact or chewed extended-release hydrocodone produced lower reported drug liking than hydrocodone solution. However, “abuse-deterrent” does not mean abuse-proof, addiction-proof, or overdose-proof.^[10]

The review emphasized that large studies after marketing were still needed to determine whether those properties reduce abuse, misuse, or related clinical harm in everyday practice. The formulation retains opioid risks, including respiratory depression (dangerously slowed breathing), physical dependence, withdrawal, misuse, addiction, and overdose.^[10]

Which Hydrocodone Products Contain Acetaminophen?

Older product names such as Vicodin, Norco, and Lortab may sound familiar. MedlinePlus marks these branded hydrocodone-acetaminophen products as no longer on the market and notes that generic alternatives may be available. Check the actual ingredients on your pharmacy label rather than relying on a remembered brand name.^[1]

Many listed hydrocodone products contain acetaminophen, a nonopioid pain medicine, but readers should not assume that every hydrocodone medicine does. DailyMed, a drug-label resource, lists hydrocodone-acetaminophen tablets, liquids, and solutions. A chronic-pain review describes single-ingredient extended-release hydrocodone, while MedlinePlus describes hydrocodone combination products used for cough.^{[11][9][10][1]}

Too much acetaminophen can cause severe liver damage. It appears in many prescription and over-the-counter medicines, so taking a hydrocodone-acetaminophen product alongside another acetaminophen-containing medicine can unintentionally duplicate the ingredient. Prescription labels may abbreviate acetaminophen as “APAP.”^[3]

The U.S. Food and Drug Administration advises against combining prescription and over-the-counter acetaminophen products unless a healthcare professional recommends it. Ask a pharmacist to check all pain, cold, flu, and sleep products before adding one. Do not take extra medicine because pain persists. Discuss the pain with the prescriber.^[3]

A practical approach is to read the product information for every active ingredient and ask a clinician or pharmacist if anything is unclear. This can reduce confusion when comparing more than one medicine. A pharmacist can help explain product-specific measuring, storage, and administration requirements.^[1]

For example, a person sees “hydrocodone” on two medication lists and assumes the products are identical. One is a pain tablet combined with acetaminophen. The other is a hydrocodone combination product used to relieve cough. Comparing only the word “hydrocodone” would miss clinically important differences.^[11][1]

How Do Hydrocodone Use, Dependence, and Addiction Differ?

These terms describe different situations. Using them accurately helps people recognize risk without labeling every patient who takes hydrocodone as addicted.

Physical dependence can occur during prescribed treatment. Opioid use disorder involves a broader pattern: at least two of eleven diagnostic symptoms or behaviors within one year. Tolerance and withdrawal do not count toward this diagnosis when opioids are taken solely under appropriate medical supervision.^[13]

Examples include taking opioids in greater amounts or for longer than intended, unsuccessful efforts to cut down, craving, spending substantial time obtaining or recovering from opioids, failing to meet important responsibilities, continuing despite social or health problems, giving up activities, or using in hazardous situations.^[12][4]

When to Seek an Assessment for Hydrocodone Addiction Signs

No single sign proves opioid use disorder. A professional assessment is worth seeking when opioid use is becoming hard to control, is interfering with daily life, continues despite harm, or repeatedly occurs outside prescription directions.

Possible reasons to ask for an assessment include:

• Taking hydrocodone in larger amounts, more often, or longer than intended.
• Repeated unsuccessful attempts to reduce or control use.
• Strong urges or cravings.
• Spending substantial time obtaining, using, or recovering from opioids.
• Missing work, school, caregiving, or household responsibilities.
• Continuing despite relationship, physical, or mental health problems.
• Giving up important activities.
• Using in dangerous circumstances.
• Experiencing withdrawal and continuing mainly to avoid it, especially alongside other signs.

Withdrawal alone does not settle the diagnosis because prescribed use can produce physical dependence. Likewise, taking hydrocodone for genuine pain does not rule out a disorder if a harmful loss-of-control pattern has developed.^[13]

A useful opening to a clinician is: “I am concerned about how this medicine is affecting me, and I want an assessment of pain, dependence, withdrawal risk, and possible opioid use disorder.” Those are related but separate questions.

What Are the Immediate Risks of Hydrocodone?

One urgent hydrocodone risk is respiratory depression, meaning breathing becomes dangerously slow, shallow, or interrupted. Hydrocodone combination products may cause life-threatening breathing problems, particularly early in treatment or after an increase in dose.^[1]

Extreme drowsiness, unusual snoring, long pauses in breathing during sleep, hallucinations, seizures, difficulty swallowing, chest pain, heartbeat changes, or a serious allergic reaction require prompt medical attention. New pain or pain from ordinarily nonpainful touch has also been reported and should be discussed with a clinician rather than answered by taking extra medication.^[1]

Do not take more hydrocodone or take it more often because pain is worsening. The National Library of Medicine advises contacting the prescriber if pain is not controlled, becomes worse, or is accompanied by new sensitivity to pain.^[1]

Sedating Combinations Can Suppress Breathing

Alcohol can worsen hydrocodone’s adverse effects, and MedlinePlus advises not drinking alcoholic beverages while taking a hydrocodone combination product.^[1]

Benzodiazepines are sedating medicines used for conditions such as anxiety, insomnia, and seizures. Combining them with opioids has resulted in severe respiratory depression and death. The Food and Drug Administration advises particular caution with this combination and other central nervous system depressants, medicines or substances that reduce brain activity and alertness.^[14]

Other potentially sedating medicines include muscle relaxants, non-benzodiazepine sleep medicines, and some medicines used to treat seizures, such as gabapentin or pregabalin. The Centers for Disease Control and Prevention advises clinicians to consider whether the benefits of these combinations outweigh their risks.^[15]

This does not mean a person should abruptly stop a benzodiazepine or opioid. Sudden benzodiazepine discontinuation can cause life-threatening withdrawal, including seizures, and requires an individualized plan. Tell each prescriber and pharmacist about all prescription medicines, over-the-counter products, and substances you use.^[14][1]

How Do You Recognize and Respond to a Hydrocodone Overdose?

Treat possible opioid overdose as an emergency. If it is unclear whether someone is intoxicated or overdosing, the Centers for Disease Control and Prevention advises responding as though it is an overdose.^[6]

Signs include:

• Inability to wake the person.
• Slow or shallow breathing, or difficulty breathing.
• Choking, gurgling, or snoring sounds in someone who cannot be awakened.
• Discolored lips, nails, or skin.
• Very small “pinpoint” pupils that do not respond to light.^[6]

Take these steps immediately:

1. Give naloxone if available and call 911. Naloxone temporarily reverses opioid overdose and is available over the counter in the United States.^[6]
2. If the person is unresponsive and not breathing normally or only gasping, begin cardiopulmonary resuscitation (CPR) according to your training and the dispatcher’s instructions. Do not delay breathing support while waiting for naloxone to work.^[5][7]
3. If they are breathing normally but unconscious and no head, neck or back injury is suspected, place them on their side. If you suspect such an injury, leave them in the position found unless moving them is necessary for safety, CPR or bleeding control. Follow the dispatcher’s instructions.^[7]
4. Repeat naloxone according to the product instructions if normal breathing does not return or symptoms come back. Stay and watch their breathing until emergency help arrives, even if they wake up.^[1][6][16]

Naloxone does not replace emergency care. The Centers for Disease Control and Prevention and MedlinePlus advise calling 911 and staying with the person until emergency help arrives.^[6][1]

If exposure may have occurred but the person is awake and breathing normally, Poison Control is available at 1-800-222-1222.^[1] If the person has collapsed, had a seizure, cannot breathe, or cannot be awakened, call 911 immediately.^[1]

What Happens When Hydrocodone Is Reduced or Stopped?

A person who has become physically dependent may develop withdrawal if hydrocodone is stopped suddenly or reduced too quickly. This can happen without opioid use disorder.^[1][8]

Reported hydrocodone withdrawal symptoms include restlessness, watery eyes, runny nose, yawning, sweating, chills, muscle or joint pain, widened pupils, irritability, anxiety, weakness, stomach cramps, insomnia, nausea, appetite loss, vomiting, diarrhea, rapid breathing, and a fast heartbeat.^[1]

These symptoms can be very distressing. Their presence indicates that the body has adapted to the medicine but does not answer whether the person has opioid use disorder, whether hydrocodone should be continued, or how rapidly it should be changed.

Why Can Returning to Hydrocodone After a Break Be Risky?

After reducing or stopping an opioid, tolerance can be lower. Suddenly returning to a previously prescribed higher dose can increase overdose risk. The Centers for Disease Control and Prevention recommends overdose education and naloxone for this risk. Discuss restarting or changing hydrocodone with the prescriber rather than resuming an old dose on your own.^[2][1]

Withdrawal Management Is Not the Same as Ongoing Treatment

Hydrocodone withdrawal management aims to make the transition away from an opioid safer and more tolerable. Lofexidine is approved to ease opioid withdrawal symptoms such as stomach cramps, muscle spasms, pounding heartbeat, aches, and sleep problems. It is not a continuing treatment for opioid use disorder.^[4]

Ongoing opioid use disorder treatment can reduce cravings and help people avoid returning to opioid use. Recovery is broader than completing withdrawal and may involve continuing medication treatment, healthcare, counseling, and other supports matched to the person’s needs over time.^[4][12]

Completing withdrawal does not mean the underlying disorder has been treated. Medicines that ease withdrawal symptoms have a different role from ongoing treatment that addresses opioid use over time.^[4]

Do not stop taking a hydrocodone combination product without talking to the prescriber. Ask how a change can be managed while addressing withdrawal symptoms, pain, and any concerns about opioid use disorder.^[1][4]

Which Treatments Help With Hydrocodone Addiction?

People with opioid use disorder who are treated with methadone or buprenorphine are less likely to die or to have an overdose than those who do not receive treatment.^[4]

Opioid use disorder is treatable. The three Food and Drug Administration-approved medications for continuing treatment are methadone, buprenorphine, and naltrexone. They differ in how they work, how treatment begins, and how they are accessed.^[4]

The options below have different everyday roles and access considerations. Lofexidine is included to clarify its limited role in withdrawal management.^[4]

These roles and access differences are described in National Institute on Drug Abuse guidance.^[4]

How Methadone Treats Opioid Use Disorder

Methadone activates opioid receptors, the sites in the brain where opioids attach and exert their effects. When taken as prescribed by people with opioid use disorder, it can reduce withdrawal and cravings without producing the intense pleasurable effects, or “high,” associated with other opioid use.^[4]

In the United States, ongoing methadone treatment for opioid use disorder is generally accessed through certified opioid treatment programs, specialized addiction-treatment services. Distance to a program and unreliable transportation can create barriers, especially in rural or small suburban communities. When contacting a program, ask how often visits would be needed and whether the schedule would work for you.^[4]

How Buprenorphine Treats Opioid Use Disorder

Buprenorphine activates opioid receptors to a lesser degree than methadone and can interfere with other opioids attaching to them. It can reduce withdrawal and cravings without producing intense intoxication in people with opioid use disorder.^[4]

Treatment options include medicines placed under the tongue or inside the cheek and extended-release injections. Some products combine buprenorphine with naloxone. Buprenorphine can be prescribed in physician offices, and telehealth (care delivered remotely, such as by phone or video) may help with access in some circumstances. Ask which formulation and appointment arrangements are available to you.^[4][17]

Starting buprenorphine needs an individual plan. Starting at the wrong point can cause precipitated withdrawal, a rapid worsening of withdrawal symptoms. Tell the clinician what opioids you last took and when, including pills obtained outside a pharmacy, and follow the starting plan they recommend.^[2]

How Naltrexone Treats Opioid Use Disorder

Naltrexone blocks opioid receptors rather than activating them. A long-acting injection is typically given monthly. Any healthcare provider with appropriate prescribing authority can prescribe it.^[4]

For patients who have been physically dependent on opioids, starting naltrexone too soon can trigger sudden withdrawal. National Institute on Drug Abuse guidance describes a typical opioid-free interval of seven to ten days before treatment. It also reports research supporting faster, clinically managed approaches. This is a transition to plan with a clinician, not a waiting schedule to attempt independently.^[4]

When successfully started and continued, naltrexone can be as effective as buprenorphine at helping people avoid a return to opioid use. That finding does not establish that the medicines are interchangeable, because initiating naltrexone is often more difficult.^[4]

What Benefits Do Methadone and Buprenorphine Offer?

Methadone and buprenorphine can both help people reduce opioid use and remain in treatment. Methadone may help some people stay in treatment longer. These benefits concern ongoing treatment, not just relief during withdrawal. Practical access also matters: distance to a methadone program and difficulty filling a buprenorphine prescription can create barriers.^[4]

Why Ongoing Buprenorphine Can Be More Helpful Than a Short Taper

In a 14-week randomized trial, researchers assigned 113 primary-care patients with prescription-opioid dependence by chance to either ongoing buprenorphine or a three-week taper, or gradual dose reduction, after six weeks of buprenorphine treatment.^[18] Everyone also received medical, nursing, and drug-counseling support.^[18]

In this trial, the difference between groups favored maintenance: the mean percentage of opioid-negative urine samples was 53.2% in the maintenance group and 35.2% in the taper group.^[18] This measures test results during treatment, not the percentage of people who recovered. Participants assigned to taper also reported more illicit-opioid-use days after buprenorphine ended.^[18]

Only 6 of 57 people assigned to taper completed the trial, compared with 37 of 56 assigned to maintenance, about 11% versus 66%.^[18] Sixteen people in the taper group restarted buprenorphine after returning to opioid use.^[18]

This trial supports ongoing maintenance over a short taper for the studied primary-care patients. It does not establish one required treatment duration for everyone, and it did not specifically study hydrocodone-only disorder.

Is Medication Just Replacing One Drug With Another?

Methadone and buprenorphine can produce physical dependence, but dependence is not identical to uncontrolled addiction. When taken as prescribed by people with opioid use disorder, they reduce withdrawal and cravings without the intense intoxication associated with other opioid use. Naltrexone is not addictive. It blocks rather than activates opioid receptors.^[4]

A qualitative study of 20 family members in rural Vermont found concerns that medication for opioid use disorder was another addiction and should be short term.^[19] Participants also valued mental health care, residential services, and family support, while describing stigma as a barrier. These interviews illuminate beliefs in one small rural group. They do not measure treatment effectiveness.^[19]

Medication and counseling can be combined as part of treatment.^[12] When comparing hydrocodone rehabilitation options, ask: “What medication treatment and mental health services do you offer? Is residential care relevant to my situation? Can family or other support people participate if I want them involved?” These questions can help clarify what a particular provider offers without assuming every person needs the same services.

What Are the Longer-Term Health Risks of Hydrocodone?

Longer-term hydrocodone use can involve continuing opioid adverse effects, physical dependence, withdrawal risk, misuse, and addiction. Extended-release hydrocodone retains risks of respiratory depression and overdose even when its formulation is intended to deter certain forms of manipulation.^[10]

Some people report stable pain benefit over time, but the available long-term study data do not identify a guaranteed responder profile. In the combined extended-release opioid analysis, many participants did not complete follow-up or did not maintain stable pain on a stable dose, and fewer met combined pain, dose, and function standards.^[9]

Long-term treatment decisions therefore need to consider more than a pain score. Useful questions include whether the medicine improves movement, sleep, work, caregiving, or another personally meaningful function, whether benefits remain stable, and whether adverse effects or unsafe combinations are emerging.

Hydrocodone Use and Mental Health

In the 2024 national survey, adults with past-year mental illness reported higher rates of past-year opioid misuse than adults without mental illness.^[12] These data are not hydrocodone-specific and do not show whether mental illness leads to opioid misuse, opioid misuse worsens mental health, or other factors contribute.^[12]

Tell the prescriber about depression or another mental illness when discussing hydrocodone treatment. For an emotional crisis or suicidal thoughts, call or text 988. For a breathing emergency or unresponsiveness, call 911.^[20][6]

Hydrocodone During Pregnancy and Other Health Conditions

Pregnancy, breastfeeding, lung disease, seizures, intestinal blockage, and liver, kidney, heart, thyroid, pancreas, or gallbladder conditions can affect medication decisions. MedlinePlus advises discussing these conditions and any pregnancy or breastfeeding with the prescriber.^[1]

Do not make a sudden medication change because of pregnancy or another new diagnosis. Both ongoing opioid exposure and abrupt withdrawal may require clinical assessment, and treatment choices depend on the individual circumstances.^[1]

How Effective Is Hydrocodone for Pain?

“Patients with pain should receive compassionate, safe, and effective pain care,” said Christopher M. Jones, then acting director of the Centers for Disease Control and Prevention’s National Center for Injury Prevention and Control, when the agency released its 2022 prescribing guideline.^[21] Concerns about dependence or opioid use disorder deserve attention alongside the reason pain treatment began.

Long-term benefit is possible for some carefully selected patients, but it is not assured. In studies combining extended-release hydrocodone and oxycodone, a minority maintained pain improvement without increasing the dose when everyone entering dose adjustment was counted. The studies excluded many higher-risk patients and had no nonopioid comparison group.^[9]

The useful question for continued treatment is whether it improves daily function as well as pain. The authors emphasized nonopioid treatment and coordinated care from different types of health professionals first, with careful selection and follow-up when opioids are used. These results do not establish that hydrocodone is preferable to another medicine.^[9]

What Do U.S. Statistics Show About Hydrocodone and Opioid Misuse?

The 2025 National Survey on Drug Use and Health estimated that 6.881 million people aged 12 or older misused prescription opioids in the past year, and 3.709 million had a prescription opioid use disorder.^[22][23] These are broader prescription-opioid figures, not hydrocodone-only estimates or counts of everyone using hydrocodone medically.^[22][23]

The survey represents the United States civilian, noninstitutionalized population aged 12 or older.^{[24][12][22][23]} It excludes active-duty military personnel and people living in settings such as jails, nursing homes, or long-term care facilities. Percentages below use the full survey population in this age range (not just people who took opioids) as their denominator.^{[24][12][22][23]}

The estimates distinguish misuse from a disorder, which is assessed using diagnostic symptoms and behaviors rather than simply whether someone used a medicine outside prescription directions. The latest figures below refer to the 2025 survey year.^[12][23]

Misuse estimates come from the survey’s drug-use tables. Disorder estimates come from its substance-use-disorder tables. The broader opioid disorder category includes prescription opioid disorder, so these rows should not be added together. None is a hydrocodone-specific disorder estimate.^[22][23][12]

For perspective, the 2025 estimate of 2.4% means about 24 of every 1,000 people aged 12 or older in the U.S. civilian, noninstitutionalized population reported past-year prescription-opioid misuse.^[22] It does not mean that 2.4% of hydrocodone patients misused their medicine, or describe an individual patient’s likelihood of developing a disorder.^[22]

The 2024 survey asked which prescription pain relievers people had used and misused during the previous year.^[12][24] Respondents reporting misuse of Vicodin, a hydrocodone product name, or hydrocodone were categorized as misusing hydrocodone products. That drug-specific category is narrower than the prescription-opioid totals above. The 2024 detailed tables were published August 6, 2025.^[12][24]

In that survey, “misuse” included using someone else’s prescription or taking one’s own medication in a greater amount or more often than directed. Consequently, misuse could be reported even when the person’s purpose was pain relief. Among people aged 12 or older who misused prescription pain relievers in 2024, 70.1% said the main reason for their most recent misuse was relieving physical pain.^[12]

That percentage applies to people who misused prescription pain relievers, not to everyone taking hydrocodone and not specifically to hydrocodone users. It does not establish that pain relief makes nonprescribed or above-directed use safe.

What Do Older Hydrocodone-Related Estimates Mean?

An analysis of the 2017 and 2018 national survey data reported that 1.4 million people had dependence on prescription pain relievers in 2018.^[25] Hydrocodone was the last pain reliever used in 33% of those with dependence, compared with oxycodone in 24%.^[25] These are historical estimates, not current hydrocodone use or disorder rates.^[25]

These figures should not be interpreted as showing that 1.4 million people had hydrocodone dependence.^[25] The denominator was broader prescription pain-reliever dependence, and the “last pain reliever used” does not prove which medicine caused or sustained the condition.^[25]

The analysis also reported use outside prescription directions: 1.5 million prescription users took a pain reliever more frequently, 1.2 million used one longer, and 1.9 million took higher amounts than prescribed.^[25] These categories concern prescription pain relievers generally and may overlap. They are not hydrocodone-only counts.^[25]

What Is Known About Mental Health and Other Drug Use?

A useful assessment considers mental health and every substance used, not hydrocodone alone. Tell the clinician about alcohol, sedatives, other opioids, and symptoms such as depression or anxiety so the care plan can address risks together.^[12][2]

What Can Overdose Statistics Tell Us About Hydrocodone?

The Centers for Disease Control and Prevention’s provisional overdose dashboard does not give a separate hydrocodone death count. It groups hydrocodone with medicines such as oxycodone and morphine in its “natural and semisynthetic opioids” category. A death involving multiple drugs can appear in more than one category, so adding category totals can count the same death more than once.^[26]

The agency’s provisional overdose dashboard reports rolling 12-month periods, not necessarily calendar years.^[26] “Provisional” means the counts are not yet final. Investigations and reporting delays can leave recent counts incomplete. Predicted counts adjust for typical delays but may not fully account for unusually long delays. These distinctions matter when interpreting whether overdose deaths have risen or fallen.^[26]

Drug-specific overdose interpretation is especially difficult when multiple substances are involved or a counterfeit pill contains fentanyl. Illegally made fentanyl may be present in counterfeit prescription-looking pills without the user’s knowledge, and overdose deaths often involve more than one drug.^[8]

A pill obtained outside a licensed pharmacy therefore cannot be assumed to contain hydrocodone merely because it looks like a prescription tablet. This counterfeit-pill risk is distinct from taking a verified pharmacy-dispensed product as directed.

How Can People Reduce Hydrocodone-Related Risks?

Risk reduction begins with knowing exactly what product is being used and making one manageable safety improvement at a time. It does not require a person to be ready to stop all opioid use.

For Someone Taking Prescribed Hydrocodone

Use the medication only as directed, and do not take extra doses because pain or cough worsens. Contact the prescriber for reassessment instead. Do not share the medicine, and keep it secured where children, visitors, and others cannot access it.^[1]

Review the complete active-ingredient list. Tell the clinician and pharmacist about alcohol use, benzodiazepines, sleep medicines, muscle relaxants, gabapentin, pregabalin, and all other prescriptions or over-the-counter products.^[14][15]

Ask about keeping naloxone nearby. Ensure that people likely to be present know where it is, how to use it, and that they must call 911 after giving it.^[1][6]

Use a medication take-back program for unwanted hydrocodone when accessible. MedlinePlus advises discussing disposal with a pharmacist and provides product-specific disposal guidance when prompt take-back is unavailable.^[1]

For Someone Using Outside Prescription Directions

Avoid pills obtained outside a licensed pharmacy because counterfeit tablets may contain fentanyl without the user knowing.^[8] Fentanyl test strips can help detect fentanyl, but they do not measure its amount and can miss it. A negative result does not establish that a drug is safe, including because other substances can still cause overdose.^[27]

Keep naloxone available, and ensure someone likely to be present knows how to use it and call 911.^{[1][14][15][6]} Avoid combining opioids with alcohol, benzodiazepines, or other sedating substances because the combination can intensify breathing suppression.^{[1][14][15][6]}

If stopping does not feel possible today, a healthcare or harm-reduction conversation can still address naloxone, overdose history, safer use, withdrawal, pain, infections, and treatment options. Readiness may change, and help need not be postponed until a crisis.

For Families and Friends

Learn overdose signs and keep naloxone where it can be reached quickly. Ask directly and calmly about current use, recent changes, mixing substances, previous overdose, and whether the person wants help finding care.

Use language that separates the person from the condition. Stigma can discourage treatment and other healthcare use, while family beliefs that medication should be brief may conflict with evidence supporting maintenance treatment.^[19][18]

Support does not require taking full responsibility for another adult’s recovery. Families can offer transportation, attend an appointment when invited, store naloxone, secure household medicines, or help compare treatment programs. They may also need their own counseling or peer support.

How Does Prescription Monitoring Support Hydrocodone Care?

A prescription-monitoring database lets a clinician review controlled medicines dispensed by pharmacies. This is a routine safety check, not an accusation. It can identify overlapping prescriptions or risky combinations. Tell the clinician about all medicines you take and discuss any record you think is incorrect.^[15]

Explore a Hydrocodone Question

Choose the guide that matches your immediate concern or the product on your label.

• Possible overdose: the hydrocodone overdose guide covers opioid and acetaminophen concerns. Call 911 for a suspected overdose.
• Reducing or stopping: read about hydrocodone withdrawal symptoms and withdrawal management.
• Continuing care: use the hydrocodone rehabilitation guide to explore treatment questions.
• Product names: learn more about Vicodin and Lortab, then verify the actual ingredients on your pharmacy label.
• Specific risks and comparisons: explore snorting hydrocodone, hydrocodone statistics, and hydrocodone versus oxycodone.

Where Can You Start Getting Help for Hydrocodone Use?

If you take prescribed hydrocodone and have no immediate emergency, start by reading the full pharmacy label. Identify whether the product treats pain or cough, whether it is extended-release, and what other active ingredients it contains. Ask a pharmacist to review possible duplicates and sedating combinations.

If you are concerned about dependence or withdrawal, arrange a medication review before making a sudden change. Ask the clinician to distinguish physical dependence, uncontrolled pain, adverse effects, misuse, and possible opioid use disorder.

If opioid use is becoming difficult to control, request an opioid use disorder assessment and ask specifically about methadone, buprenorphine, and naltrexone. A discussion of all three options is more informative than assuming that withdrawal management alone is treatment.

If you are not ready to stop, take an immediate harm-reduction step: obtain naloxone, avoid counterfeit pills, and avoid mixing opioids with alcohol or sedating medicines. Make sure someone likely to be present knows how to respond to an overdose and call 911.^{[8][1][14][6]}

If you are supporting someone else, learn overdose response, secure household medications, offer practical help without shame, and remember that ongoing medication treatment may be a valid form of recovery.

For treatment referrals, call the Substance Abuse and Mental Health Services Administration National Helpline at 1-800-662-HELP (4357) or visit FindTreatment.gov.^[28] For an emotional crisis or suicidal thoughts, call or text 988.^[20] Call 911 for a suspected overdose or other immediate, life-threatening emergency.^[6]